QurAlis

QurAlis, a subsidiary of Cambridge-based Q-State Biosciences, is focused on developing new therapies for amyotrophic lateral sclerosis (ALS). Q-State Biosciences, a stem cell biotechnology company, has developed proprietary technology in stem cells, and QurAlis holds exclusive rights to use it in ALS drug discovery.